Showing results (461-470 of 517) with videos related to

Sort By:
Pageof 52
Updates in Surgery|August 26, 2025
Liver hypertrophy techniques: a position paper from the Italian Group of Regenerative and Occlusive Worldwide-used techniques of hepatic Hypertrophy (I GROWtoH)Matteo Serenari, Francesca Ratti, Mohammed Abu Hilal, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 21, 2025
Stratifying the risk in liver surgery: performance in an Italian cohort of 3.280 liver resection for HCCGuido Costa, Matteo Donadon, Federica Cipriani, et al.
JAMA Surgery|December 28, 2022
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After SurgerySimone Famularo, Matteo Donadon, Federica Cipriani, et al.
Annals of Surgery|March 30, 2023
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic SyndromeGiammauro Berardi, Tommy Ivanics, Gonzalo Sapisochin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 12, 2021
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinibIlario Giovanni Rapposelli, Toshifumi Tada, Shigeo Shimose, et al.
Hepatology (Baltimore, Md.)|January 16, 2023
Model to predict major complications following liver resection for HCC in patients with metabolic syndromeGiammauro Berardi, Francesca Ratti, Carlo Sposito, et al.
Surgical Endoscopy|April 17, 2023
Robotic versus laparoscopic liver resections for hepatolithiasis: an international multicenter propensity score matched analysisBong Jun Kwak, Jae Hoon Lee, Ken Min Chin, et al.
BMJ Open|November 25, 2025
LIVERATION trial: a multicentre European randomised study on radiofrequency margin coagulation and its impact on oncological outcomes after liver surgery - study protocolEduardo Luque Villalobos, Benedetto Ielpo, Luca Aldrighetti, et al.
Langenbeck'S Archives of Surgery|August 10, 2024
Single large hepatocellular carcinoma > 5 cm with surgical indication: is it mandatory a major hepatectomy? a propensity-score weighted analysisMattia Garancini, Matteo Serenari, Simone Famularo, et al.
Targeted Oncology|May 1, 2024
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter StudyMargherita Rimini, Gianluca Masi, Sara Lonardi, et al.
Pageof 52